alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with ketamine in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.00) | 18.7374 |
| 1990's | 11 (44.00) | 18.2507 |
| 2000's | 5 (20.00) | 29.6817 |
| 2010's | 6 (24.00) | 24.3611 |
| 2020's | 2 (8.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baudry, M; Maren, S; Shors, TJ; Thompson, RF; Tocco, G | 1 |
| Heinemann, U; Mudrick, LA | 1 |
| Davies, SN; Drejer, J; Fletcher, EJ; Honoré, T; Jacobsen, P; Lodge, D; Nielsen, FE | 1 |
| Fedele, E; Raiteri, M; Versace, P | 1 |
| Hu, B; Nissen, R; Renaud, LP | 1 |
| Headley, PM; Herrero, JF; Parsons, CG | 1 |
| Dickie, BG; Greenfield, SA; Jones, SA; Klegeris, A | 1 |
| Lücke, T; Neugebauer, V; Schaible, HG | 1 |
| Henry, JL; Radhakrishnan, V | 1 |
| Chizh, BA; Headley, PM | 1 |
| Glowinski, J; Pirot, S; Thierry, AM | 1 |
| Sharp, JW | 1 |
| Shi, WX; Zhang, XX | 1 |
| Alonso, TJ; Castro Fuentes, R; García Dopico, J; González Hernández, T; Perdomo Díaz, J; Rodríguez Díaz, M | 1 |
| Chizh, BA; Christoph, T; Englberger, W; Parsons, CG; Schiene, K | 1 |
| Chen, G; Du, J; Maeng, S; Manji, HK; McCammon, J; Schloesser, RJ; Zarate, CA | 1 |
| Diazgranados, N; Machado-Vieira, R; Salvadore, G; Zarate, CA | 1 |
| Castner, SA; Holden, DE; Menniti, FS; Roberts, BM; Schmidt, CJ; Seymour, PA; Shaffer, CL; Williams, GV | 1 |
| Akinfiresoye, L; Tizabi, Y | 1 |
| Machado-Vieira, R; Zarate, CA | 1 |
| Cavalleri, L; Chiamulera, C; Collo, G; Kunath, T; Merlo Pich, E; Millan, MJ; Spano, PF | 1 |
| Gilbert, JR; Nugent, AC; Wills, KE; Yarrington, JS; Zarate, CA | 1 |
| Brooks, G; Hasekiu, E; Ingle Gonzalez, JE; Kusi, M; Noakes, J | 1 |
| Georgiou, P; Gould, TD; Rudolph, U; Thompson, SM; Troppoli, TA; Zanos, P | 1 |
| Hara, H; Kimura, H; Suzuki, A | 1 |
2 review(s) available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and ketamine
| Article | Year |
|---|---|
Ketamine and the next generation of antidepressants with a rapid onset of action.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Antidepressive Agents; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Excitatory Amino Acid Antagonists; Humans; Ketamine; Receptors, N-Methyl-D-Aspartate; Severity of Illness Index; Time Factors | 2009 |
Role of the AMPA receptor in antidepressant effects of ketamine and potential of AMPA receptor potentiators as a novel antidepressant.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Antidepressive Agents; Humans; Ketamine; Receptors, AMPA; Seizures | 2023 |
1 trial(s) available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and ketamine
| Article | Year |
|---|---|
Glutamatergic Signaling Drives Ketamine-Mediated Response in Depression: Evidence from Dynamic Causal Modeling.
Topics: Adolescent; Adult; Affect; Aged; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Antidepressive Agents; Brain; Cross-Over Studies; Depressive Disorder, Major; Double-Blind Method; Evoked Potentials, Somatosensory; Excitatory Amino Acid Antagonists; Female; Glutamic Acid; Humans; Infusions, Intravenous; Ketamine; Magnetoencephalography; Male; Middle Aged; Models, Neurological; N-Methylaspartate; Time Factors; Treatment Outcome; Young Adult | 2018 |
22 other study(ies) available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and ketamine
| Article | Year |
|---|---|
Long-term potentiation is associated with increased [3H]AMPA binding in rat hippocampus.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Analysis of Variance; Animals; Autoradiography; Electric Stimulation; Evoked Potentials; Hippocampus; Ibotenic Acid; In Vitro Techniques; Ketamine; Male; Multivariate Analysis; Phencyclidine; Rats; Receptors, AMPA; Receptors, Neurotransmitter; Synapses; Tritium | 1992 |
Quisqualate-induced changes in extracellular sodium and calcium concentrations persist in the combined presence of NMDA and non-NMDA receptor antagonists in rat hippocampal slices.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Calcium; Evoked Potentials; Extracellular Space; Glutamates; Glutamic Acid; Hippocampus; Ibotenic Acid; In Vitro Techniques; Ketamine; Membrane Potentials; N-Methylaspartate; Quinoxalines; Quisqualic Acid; Rats; Receptors, N-Methyl-D-Aspartate; Sodium | 1990 |
Quinoxalinediones: potent competitive non-NMDA glutamate receptor antagonists.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Action Potentials; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Aspartic Acid; Binding, Competitive; Cell Membrane; Cerebral Cortex; Ibotenic Acid; Kainic Acid; Ketamine; N-Methylaspartate; Neurons; Piperazines; Quinoxalines; Rats; Receptors, AMPA; Receptors, Drug; Receptors, Glutamate; Receptors, Kainic Acid; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter; Spinal Cord | 1988 |
Evaluation of the mechanisms underlying the kainate-induced impairment of [3H]dopamine release in the rat striatum.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Corpus Striatum; Dizocilpine Maleate; Dopamine; Electric Stimulation; Kainic Acid; Ketamine; Male; N-Methylaspartate; Neuromuscular Depolarizing Agents; Neurons, Afferent; Pipecolic Acids; Quinoxalines; Rats; Rats, Sprague-Dawley | 1993 |
N-methyl-D-aspartate receptor antagonist ketamine selectively attenuates spontaneous phasic activity of supraoptic vasopressin neurons in vivo.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Electrophysiology; Injections, Intravenous; Ketamine; Male; Neurons; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Supraoptic Nucleus; Vasopressins | 1994 |
Memantine selectively depresses NMDA receptor-mediated responses of ratspinal neurones in vivo.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Blood Pressure; Dose-Response Relationship, Drug; Injections, Intravenous; Iontophoresis; Kainic Acid; Ketamine; Male; Memantine; Neurons; Nociceptors; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Spinal Cord | 1994 |
The subthalamo-nigral pathway regulates movement and concomitant acetylcholinesterase release from the substantia nigra.
Topics: Acetylcholinesterase; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Dendrites; Electric Stimulation; Electrophysiology; Excitatory Amino Acid Agonists; Guinea Pigs; Ketamine; Male; Motor Activity; N-Methylaspartate; Neural Pathways; Substantia Nigra; Urethane | 1994 |
Differential effects of N-methyl-D-aspartate (NMDA) and non-NMDA receptor antagonists on the responses of rat spinal neurons with joint input.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Ibotenic Acid; Ketamine; Male; Neurons; Pain; Physical Stimulation; Quinoxalines; Rats; Rats, Wistar; Receptors, Amino Acid; Receptors, N-Methyl-D-Aspartate; Spinal Cord | 1993 |
Excitatory amino acid receptor mediation of sensory inputs to functionally identified dorsal horn neurons in cat spinal cord.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Cats; Decerebrate State; Evoked Potentials; Glutamates; Glutamic Acid; Ibotenic Acid; Kainic Acid; Ketamine; Kynurenic Acid; N-Methylaspartate; Neurons; Quinoxalines; Quisqualic Acid; Receptors, Amino Acid; Receptors, N-Methyl-D-Aspartate; Spinal Cord; Synapses | 1993 |
Thyrotropin-releasing hormone facilitates spinal nociceptive responses by potentiating NMDA receptor-mediated transmission.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Analysis of Variance; Animals; Dose-Response Relationship, Drug; Drug Synergism; Excitatory Amino Acid Antagonists; Hot Temperature; Ketamine; Male; N-Methylaspartate; Pain Measurement; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Spinal Cord; Thyrotropin-Releasing Hormone | 1996 |
Excitatory responses evoked in prefrontal cortex by mediodorsal thalamic nucleus stimulation: influence of anaesthesia.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Anesthesia; Anesthetics; Animals; Halothane; Ketamine; Male; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Thalamus | 1995 |
PCP and ketamine inhibit non-NMDA glutamate receptor mediated hsp70 induction.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Dentate Gyrus; Female; Hippocampus; HSP70 Heat-Shock Proteins; Ketamine; Phencyclidine; Rats; Rats, Sprague-Dawley | 1996 |
Dendritic glutamate-induced bursting in the prefrontal cortex: further characterization and effects of phencyclidine.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Dendrites; Electrophysiology; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glutamates; Hallucinogens; Ketamine; Lysine; Male; Membrane Potentials; N-Methylaspartate; Phencyclidine; Prefrontal Cortex; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Synapses | 2003 |
Extracellular taurine in the substantia nigra: taurine-glutamate interaction.
Topics: Adrenergic Agents; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Aspartic Acid; Brain Chemistry; Calcium; Chelating Agents; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Interactions; Egtazic Acid; Excitatory Amino Acid Antagonists; Extracellular Space; gamma-Aminobutyric Acid; Glutamic Acid; Kainic Acid; Ketamine; Male; Membrane Potentials; Microdialysis; N-Methylaspartate; Oxidopamine; Potassium; Rats; Rats, Sprague-Dawley; Substantia Nigra; Taurine; Time Factors; Zinc | 2004 |
The antiallodynic effect of NMDA antagonists in neuropathic pain outlasts the duration of the in vivo NMDA antagonism.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Analgesics, Opioid; Animals; Cold Temperature; Constriction, Pathologic; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Fentanyl; Iontophoresis; Ketamine; Male; Motor Activity; N-Methylaspartate; Pain; Peripheral Nervous System Diseases; Phthalazines; Posterior Horn Cells; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Spinal Cord | 2006 |
Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Depressive Disorder, Major; Excitatory Amino Acid Antagonists; Helplessness, Learned; Hippocampus; Ketamine; Male; Mice; Phosphorylation; Psychomotor Performance; Receptors, AMPA; Swimming; Time Factors | 2008 |
Prevention of ketamine-induced working memory impairments by AMPA potentiators in a nonhuman primate model of cognitive dysfunction.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Analysis of Variance; Animals; Animals, Newborn; Area Under Curve; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Excitatory Amino Acid Agonists; Ketamine; Macaca fascicularis; Macaca mulatta; Memory Disorders; Memory, Short-Term; Motor Activity; Neuropsychological Tests; Reaction Time; Sulfonamides; Thiophenes; Time Factors | 2010 |
Antidepressant effects of AMPA and ketamine combination: role of hippocampal BDNF, synapsin, and mTOR.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Depression; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Hippocampus; Ketamine; Male; Rats; Rats, Inbred WKY; Receptors, N-Methyl-D-Aspartate; Swimming; Synapsins; TOR Serine-Threonine Kinases | 2013 |
GSK-3: A key regulatory target for ketamine's rapid antidepressant effects mediated by enhanced AMPA to NMDA throughput.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Antidepressive Agents; Bipolar Disorder; Glycogen Synthase Kinase 3; Humans; Ketamine; N-Methylaspartate; Receptors, N-Methyl-D-Aspartate | 2016 |
Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signaling.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Antidepressive Agents; Brain; Brain-Derived Neurotrophic Factor; Dopaminergic Neurons; Hippocampus; Humans; Induced Pluripotent Stem Cells; Ketamine; Mesencephalon; Mice; Mice, Inbred C57BL; Mice, Knockout; Neuronal Plasticity; Receptors, AMPA; Receptors, Dopamine D3; Receptors, Glutamate; Signal Transduction; TOR Serine-Threonine Kinases | 2018 |
Modeling Schizophrenia's Abnormal Cortical Neural Synchrony in Monkeys.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Haplorhini; Humans; Ketamine; N-Methylaspartate; Schizophrenia | 2018 |
Negative Allosteric Modulation of Gamma-Aminobutyric Acid A Receptors at α5 Subunit-Containing Benzodiazepine Sites Reverses Stress-Induced Anhedonia and Weakened Synaptic Function in Mice.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Anhedonia; Animals; Benzodiazepines; Female; gamma-Aminobutyric Acid; Humans; Ketamine; Male; Mice; N-Methylaspartate; Receptors, GABA; Receptors, GABA-A; Sucrose | 2022 |